According to the proposed rule, filed Dec. 31, 2014, “stage 3 will focus on improving healthcare outcomes and further advance interoperability.”
The proposed rule outlines the criteria eligible hospitals, eligible providers and critical access hospitals must meet in order to demonstrate meaningful use under the EHR incentive program.
The proposed rule includes changes to the reporting period, timelines and meaningful use program structure, which “will provide a flexible, yet, clearer framework to ensure future sustainability of the EHR program and reduce confusion stemming from multiple stage requirements,” according to the filing.
Stage 3 will not go into effect until 2017.
The proposed rule will be posted in the Federal Register once OMB completes its review, a CMS spokesperson told Health Data Management.
More articles on meaningful use:
Physicians less confident than nursing staff in organization’s ability to navigate MU
Massachusetts finalizes rule requiring physicians to demonstrate EHR proficiency
Congress asks HHS for shorter MU reporting period
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
